HUM-MOLGEN events: Advances in Designing CANCER VACCINES

HUM-MOLGEN -> Events -> Meetings and Conferences

March 17, 2003

The Knowledge Foundation, Inc., Boston, MA USA
April 23 - 25, 2003

The immunotherapeutic approach for the treatment of cancer, while in the early stages of development, is identified as a promising tool for fighting this disease. In order to improve the immunotherapy, it is necessary to understand how the immune system interacts with cancer cells and how to induce a strong immune response.
In it’s 2nd year, this conference provides you with the latest strategies for designing immunotherapeutic based cancer treatments. Gain important insights in cancer vaccine research as leading experts discuss their findings on:
• Dendritic Cell Based Immunotherapies
• Ongoing Clinical Trials
• Novel Immune Enhancers
• Immune Monintoring

Furthermore, various approaches to designing cancer vaccines will be presented such as: Peptide Based Vaccines, Carcinoembryonic Based Antigen, Fully Human Antibodies, Inducing CD8+ T cells, Heat Shock Proteins and Telomerase Reverse Transcriptase.

Organized by:

The Knowledge Foundation, Inc.

Invited Speakers:

William Bains,
Neil Berinstein,
Heather L. Davis,
David Higgins,
Holly Horton,
Henry G. Lamparski,
Reiner Laus,
Dante J. Marciani,
Francesco M. Marincola,
Lucio Miele
Smita Nair,
Rienk Offringa,
James B. Rottman,
Margarita Salcedo,
Michael Salgaller
Michael Steller,
Ashley J. Stevens,
Robert Urban,
Geeta S. Vemuri,
Mike Whelan,
Yuanxin Xu,
Michael Yellin,
Jonathan Yewdell,
Eli Young,
Maurizio Zanetti,

Deadline for Abstracts:

none

Registration:

registration is possible either via phone: 617-232 7400 fax:617-232 9171 or online at www.knowledgefoundation.com

E-mail:

meder@knowledgefoundation.com

Posted by:

Margit Eder

Host:

141.149.163.2